AUPH

Aurinia Pharmaceuticals Inc.

Price Chart

Latest Quote

$16.21

-0.01 (-0.06%)

Current Price

Previous Close	$16.22
Open	$16.22
Day High	$16.48
Day Low	$16.21
Volume	141,716

Fetched: 2026-06-17T14:42:58

Stock Information

Shares Outstanding	128.60M
Total Debt	$68.64M
Cash Equivalents	$378.52M
Revenue	$298.30M
Net Income	$298.21M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$2.08B
P/E Ratio	7.50
EPS (TTM)	$2.16
Exchange	NGM

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$1.78B
Sales	$298.30M
Income	$298.21M
Book/sh	$4.34
Cash/sh	$2.94
Employees	128

Financial Ratios

Quick Ratio	4.95
Current Ratio	5.55
Debt/Eq	12.09
EPS Growth TTM	47.20%

Returns & Margins

ROA	13.66%
ROE	64.98%
Gross Margin	78.27%
Operating Margin	53.31%
Profit Margin	99.97%

Ownership

Insider Ownership	7.53%
Institutional Ownership	60.22%
Insider & Institutional transactions data not available

Valuation Ratios

Forward P/E	14.50
P/S	6.99
P/B	3.73

Analyst Data

Recommendation	none
Target Price	$17.00

Technical Indicators

SMA20	$15.65
SMA50	$15.76
SMA200	$14.54
RSI	61.75
ATR	0.5246

Shares Float	126.24M
Short Float	7.60%
Short Ratio	6.92
Volatility	1.43
Rel Volume	0.12

Performance History

Week	+2.72%
Month	+6.09%
Quarter	+12.02%
6 Months	+2.27%
YTD	+5.60%
Year	+98.17%
3 Years	+62.26%
5 Years	+27.84%
10 Years	+525.87%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-17	$16.21	141,716
2026-06-15	$16.00	1,122,700
2026-06-12	$15.82	673,600
2026-06-11	$15.85	905,400
2026-06-10	$15.66	1,018,600
2026-06-09	$15.78	982,500
2026-06-08	$15.66	783,600
2026-06-05	$15.84	1,275,500
2026-06-04	$16.37	2,629,000
2026-06-03	$15.67	1,692,000
2026-06-02	$15.39	1,304,500
2026-06-01	$15.31	1,203,000
2026-05-29	$15.33	1,304,700
2026-05-28	$15.35	598,100
2026-05-27	$15.54	2,445,900
2026-05-26	$15.19	893,200
2026-05-22	$15.22	994,000
2026-05-21	$15.45	919,900
2026-05-20	$15.90	1,347,900
2026-05-19	$15.55	775,500
2026-05-18	$15.60	1,205,300

About Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.

📰 Latest News

Aurinia Pharmaceuticals and Four More Stocks See Activist Action

Barrons.com • 2026-06-12T22:47:00Z

A Fresh Look At Aurinia Pharmaceuticals (AUPH) Valuation After Recent Share Price Consolidation

Simply Wall St. • 2026-06-11T14:11:48Z

Health Care Roundup: Market Talk

The Wall Street Journal • 2026-06-09T21:06:00Z

Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million

Motley Fool • 2026-06-07T12:17:26Z

We Believe Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings Are A Poor Guide For Its Profitability

Simply Wall St. • 2026-05-15T10:38:03Z

Aurinia Pharmaceuticals Inc. Just Beat EPS By 28%: Here's What Analysts Think Will Happen Next

Simply Wall St. • 2026-05-09T13:23:50Z

Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top Estimates

Zacks • 2026-05-07T15:15:03Z

ARS Pharmaceuticals, Inc. (SPRY) Soars 7.1%: Is Further Upside Left in the Stock?

Zacks • 2026-04-23T12:41:00Z

United rises on IPF results; Biogen scores positive lupus data and an approval

BioPharma Dive • 2026-03-30T15:00:00Z

Does Aurinia’s Tang‑Led Leadership Overhaul Reshape the Bull Case for Aurinia Pharmaceuticals (AUPH)?

Simply Wall St. • 2026-03-29T06:03:59Z

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$32,665,000	$28,248,000	$14,148,000	$5,664,000
Cost Of Revenue	$32,665,000	$28,248,000	$14,148,000	$5,664,000
Total Revenue	$283,055,000	$235,133,000	$175,513,000	$134,030,000
Operating Revenue	$283,055,000	$235,133,000	$175,513,000	$134,030,000
Expenses
Interest Expense	$4,330,000	$4,835,000	$2,775,000	$0
Total Expenses	$176,494,000	$216,714,000	$267,204,000	$245,500,000
Other Income Expense	$-1,647,000	$-23,106,000	-	-
Net Non Operating Interest Income Expense	$9,243,000	$12,135,000	$14,222,000	$5,118,000
Interest Expense Non Operating	$4,330,000	$4,835,000	$2,775,000	$0
Operating Expense	$143,829,000	$188,466,000	$253,056,000	$239,836,000
Other Operating Expenses	$9,530,000	$-4,347,000	$8,379,000	$-1,523,000
Selling And Marketing Expense	$3,208,000	$14,094,000	$18,287,000	-
General And Administrative Expense	$98,586,000	$157,934,000	$195,036,000	$196,371,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$287,202,000	$5,752,000	$-78,020,000	$-108,180,000
Net Interest Income	$9,243,000	$12,135,000	$14,222,000	$5,118,000
Interest Income	$13,573,000	$16,970,000	$16,997,000	$5,118,000
Normalized Income	$288,503,130	$23,596,483	$-78,020,000	$-108,180,000
Net Income From Continuing And Discontinued Operation	$287,202,000	$5,752,000	$-78,020,000	$-108,180,000
Total Operating Income As Reported	$104,914,000	$-4,687,000	$-91,691,000	$-111,470,000
Net Income Common Stockholders	$287,202,000	$5,752,000	$-78,020,000	$-108,180,000
Net Income	$287,202,000	$5,752,000	$-78,020,000	$-108,180,000
Net Income Including Noncontrolling Interests	$287,202,000	$5,752,000	$-78,020,000	$-108,180,000
Net Income Continuous Operations	$287,202,000	$5,752,000	$-78,020,000	$-108,180,000
Pretax Income	$114,157,000	$7,448,000	$-77,469,000	$-106,352,000
Special Income Charges	$-1,647,000	$-23,106,000	$0	$0
Interest Income Non Operating	$13,573,000	$16,970,000	$16,997,000	$5,118,000
Operating Income	$106,561,000	$18,419,000	$-91,691,000	$-111,470,000
Gross Profit	$250,390,000	$206,885,000	$161,365,000	$128,366,000
Depreciation Amortization Depletion Income Statement	-	-	-	-
Depreciation And Amortization In Income Statement	-	-	-	-
Amortization Of Intangibles Income Statement	-	-	-	-
Per Share
Diluted EPS	$2.07	$0.04	$-0.54	$-0.76
Basic EPS	$2.14	$0.04	$-0.54	$-0.76
Other
Tax Effect Of Unusual Items	$-345,870	$-5,261,517	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$139,583,000	$54,834,000	$-63,047,000	$-103,646,000
Total Unusual Items	$-1,647,000	$-23,106,000	$0	$0
Total Unusual Items Excluding Goodwill	$-1,647,000	$-23,106,000	$0	$0
Reconciled Depreciation	$19,449,000	$19,445,000	$11,647,000	$2,706,000
EBITDA (Bullshit earnings)	$137,936,000	$31,728,000	$-63,047,000	$-103,646,000
EBIT	$118,487,000	$12,283,000	$-74,694,000	$-106,352,000
Diluted Average Shares	$138,700,000	$146,194,000	$143,236,000	$141,915,000
Basic Average Shares	$134,367,000	$143,057,000	$143,236,000	$141,915,000
Diluted NI Availto Com Stockholders	$287,202,000	$5,752,000	$-78,020,000	$-108,180,000
Tax Provision	$-173,045,000	$1,696,000	$551,000	$1,828,000
Restructuring And Mergern Acquisition	$1,647,000	$23,106,000	$0	$0
Research And Development	$32,505,000	$20,785,000	$49,641,000	$44,988,000
Selling General And Administration	$101,794,000	$172,028,000	$195,036,000	$196,371,000
Other Gand A	$41,299,000	$53,062,000	$195,036,000	$196,371,000
Salaries And Wages	$57,287,000	$104,872,000	$119,279,000	$110,567,000
Amortization	-	-	-	-

Fetched: 2026-06-17

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$577,570,000	$373,123,000	$372,977,000	$399,010,000
Total Assets	$751,587,000	$550,645,000	$548,062,000	$470,860,000
Total Non Current Assets	$259,620,000	$104,049,000	$123,262,000	$28,321,000
Other Non Current Assets	$93,000	$823,000	$1,517,000	$13,339,000
Non Current Deferred Assets	$176,194,000	$0	-	-
Non Current Deferred Taxes Assets	$176,194,000	$0	-	-
Goodwill And Other Intangible Assets	$3,761,000	$4,355,000	$4,977,000	$6,425,000
Other Intangible Assets	$3,761,000	$4,355,000	$4,977,000	$6,425,000
Current Assets	$491,967,000	$446,596,000	$424,800,000	$442,539,000
Other Current Assets	$1,080,000	$1,129,000	$1,031,000	$1,334,000
Prepaid Assets	$5,746,000	$11,219,000	$9,486,000	$13,580,000
Inventory	$45,690,000	$39,228,000	$39,705,000	$24,752,000
Receivables	$41,454,000	$36,544,000	$24,089,000	$13,483,000
Accounts Receivable	$41,454,000	$36,544,000	$24,089,000	$13,483,000
Cash Cash Equivalents And Short Term Investments	$397,997,000	$358,476,000	$350,489,000	$389,390,000
Cash And Cash Equivalents	$80,213,000	$83,433,000	$48,875,000	$94,172,000
Debt
Total Debt	$74,812,000	$79,369,000	$97,607,000	$8,088,000
Long Term Debt And Capital Lease Obligation	$57,222,000	$64,297,000	$82,009,000	$7,152,000
Current Debt And Capital Lease Obligation	$17,590,000	$15,072,000	$15,598,000	$936,000
Liabilities
Total Liabilities Net Minority Interest	$170,256,000	$173,167,000	$170,108,000	$65,425,000
Total Non Current Liabilities Net Minority Interest	$76,532,000	$75,404,000	$92,920,000	$19,318,000
Other Non Current Liabilities	$6,662,000	$9,408,000	$3,311,000	$12,166,000
Non Current Deferred Liabilities	$12,648,000	$1,699,000	-	$12,166,000
Current Liabilities	$93,724,000	$97,763,000	$77,188,000	$46,107,000
Other Current Liabilities	$2,480,000	$1,531,000	$1,588,000	$2,033,000
Current Deferred Liabilities	$3,720,000	$11,002,000	$4,813,000	$3,148,000
Payables And Accrued Expenses	$69,934,000	$70,158,000	$55,189,000	$39,990,000
Payables	$5,323,000	$5,690,000	$5,127,000	$3,712,000
Total Tax Payable	$2,010,000	$503,000	$667,000	$625,000
Accounts Payable	$3,313,000	$5,187,000	$4,327,000	$3,087,000
Tradeand Other Payables Non Current	-	-	$0	-
Income Tax Payable	-	-	$667,000	$625,000
Equity
Common Stock Equity	$581,331,000	$377,478,000	$377,954,000	$405,435,000
Total Equity Gross Minority Interest	$581,331,000	$377,478,000	$377,954,000	$405,435,000
Stockholders Equity	$581,331,000	$377,478,000	$377,954,000	$405,435,000
Gains Losses Not Affecting Retained Earnings	$-599,000	$-647,000	$-730,000	$-1,061,000
Other Equity Adjustments	$-599,000	$-647,000	$-730,000	$-1,061,000
Retained Earnings	$-649,368,000	$-936,570,000	$-942,322,000	$-864,302,000
Other
Ordinary Shares Number	$132,323,000	$140,883,000	$143,833,000	$142,268,000
Share Issued	$132,323,000	$140,883,000	$143,833,000	$142,268,000
Tangible Book Value	$577,570,000	$373,123,000	$372,977,000	$399,010,000
Invested Capital	$581,331,000	$377,478,000	$377,954,000	$405,435,000
Working Capital	$398,243,000	$348,833,000	$347,612,000	$396,432,000
Capital Lease Obligations	$74,812,000	$79,369,000	$97,607,000	$8,088,000
Total Capitalization	$581,331,000	$377,478,000	$377,954,000	$405,435,000
Additional Paid In Capital	$111,263,000	$126,999,000	$120,788,000	$85,489,000
Capital Stock	$1,120,035,000	$1,187,696,000	$1,200,218,000	$1,185,309,000
Common Stock	$1,120,035,000	$1,187,696,000	$1,200,218,000	$1,185,309,000
Non Current Deferred Revenue	$12,648,000	$1,699,000	-	-
Long Term Capital Lease Obligation	$57,222,000	$64,297,000	$82,009,000	$7,152,000
Current Deferred Revenue	$3,720,000	$11,002,000	$4,813,000	$3,148,000
Current Capital Lease Obligation	$17,590,000	$15,072,000	$15,598,000	$936,000
Current Accrued Expenses	$64,611,000	$64,468,000	$50,062,000	$36,278,000
Net PPE	$79,572,000	$98,871,000	$116,567,000	$8,557,000
Accumulated Depreciation	$-3,153,000	$-2,533,000	$-1,910,000	$-1,455,000
Gross PPE	$82,725,000	$101,404,000	$118,477,000	$10,012,000
Leases	$3,243,000	$3,243,000	$3,243,000	$2,978,000
Other Properties	$77,461,000	$96,140,000	$113,213,000	$4,907,000
Machinery Furniture Equipment	$2,021,000	$2,021,000	$2,021,000	$1,872,000
Properties	$0	$0	$0	$0
Finished Goods	$379,000	$903,000	$583,000	$1,476,000
Work In Process	$44,653,000	$36,623,000	$37,376,000	$21,059,000
Raw Materials	$658,000	$1,702,000	$1,746,000	$2,217,000
Other Short Term Investments	$317,784,000	$275,043,000	$301,614,000	$295,218,000
Investments And Advances	-	$0	$201,000	$0
Treasury Shares Number	-	-	$0	-
Dueto Related Parties Non Current	-	-	$7,600,000	-
Dueto Related Parties Current	-	-	$800,000	-
Construction In Progress	-	-	$0	$255,000

Fetched: 2026-06-17

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$135,406,000	$44,107,000	$-34,179,000	$-79,821,000
Operating Activities
Operating Cash Flow	$135,658,000	$44,388,000	$-33,461,000	$-79,529,000
Cash Flow From Continuing Operating Activities	$135,658,000	$44,388,000	$-33,461,000	$-79,529,000
Operating Gains Losses	$9,685,000	$-5,910,000	$5,949,000	-
Investing Activities
Capital Expenditure	$-252,000	$-281,000	$-718,000	$-292,000
Investing Cash Flow	$-32,768,000	$39,262,000	$-6,706,000	$-60,632,000
Cash Flow From Continuing Investing Activities	$-32,768,000	$39,262,000	$-6,706,000	$-60,632,000
Net Other Investing Changes	-	$-43,000	$-11,864,000	$-663,000
Capital Expenditure Reported	-	-	-	$0
Financing Activities
Repurchase Of Capital Stock	$-98,156,000	$-40,239,000	$0	$0
Financing Cash Flow	$-106,110,000	$-49,092,000	$-5,130,000	$2,433,000
Cash Flow From Continuing Financing Activities	$-106,110,000	$-49,092,000	$-5,130,000	$2,433,000
Net Other Financing Charges	$-9,764,000	$-6,134,000	$-2,279,000	$-1,040,000
Net Common Stock Issuance	$-98,156,000	$-40,239,000	$0	$0
Issuance Of Capital Stock	-	-	$0	$0
Common Stock Issuance	-	-	$0	$0
Other
Repayment Of Debt	$-13,136,000	$-11,989,000	$-10,025,000	$0
Income Tax Paid Supplemental Data	$2,816,000	$2,184,000	$496,000	$1,979,000
End Cash Position	$80,213,000	$83,433,000	$48,875,000	$94,172,000
Beginning Cash Position	$83,433,000	$48,875,000	$94,172,000	$231,900,000
Changes In Cash	$-3,220,000	$34,558,000	$-45,297,000	$-137,728,000
Proceeds From Stock Option Exercised	$14,946,000	$9,270,000	$7,174,000	$3,473,000
Common Stock Payments	$-98,156,000	$-40,239,000	$0	$0
Net Issuance Payments Of Debt	$-13,136,000	$-11,989,000	$-10,025,000	$0
Net Long Term Debt Issuance	$-13,136,000	$-11,989,000	$-10,025,000	$0
Long Term Debt Payments	$-13,136,000	$-11,989,000	$-10,025,000	$0
Net Investment Purchase And Sale	$-32,516,000	$39,586,000	$5,876,000	$-59,677,000
Sale Of Investment	$494,134,000	$585,418,000	$529,376,000	$464,316,000
Purchase Of Investment	$-526,650,000	$-545,832,000	$-523,500,000	$-523,993,000
Net PPE Purchase And Sale	$-252,000	$-281,000	$-718,000	$-292,000
Purchase Of PPE	$-252,000	$-281,000	$-718,000	$-292,000
Change In Working Capital	$-8,783,000	$5,448,000	$-5,608,000	$-6,817,000
Change In Other Working Capital	$3,668,000	$5,789,000	$3,763,000	$3,048,000
Change In Other Current Liabilities	$-802,000	$-750,000	$-673,000	$-652,000
Change In Other Current Assets	$730,000	$31,000	$-16,000	$-363,000
Change In Payables And Accrued Expense	$-6,529,000	$14,190,000	$13,394,000	$699,000
Change In Accrued Expense	$-4,655,000	$13,330,000	$12,154,000	$1,491,000
Change In Payable	$-1,874,000	$860,000	$1,240,000	$-792,000
Change In Account Payable	$-1,874,000	$860,000	$1,240,000	$-792,000
Change In Prepaid Assets	$5,522,000	$-1,834,000	$4,399,000	$-2,404,000
Change In Inventory	$-6,462,000	$477,000	$-15,869,000	$-9,072,000
Change In Receivables	$-4,910,000	$-12,455,000	$-10,606,000	$1,927,000
Changes In Account Receivables	$-4,910,000	$-12,455,000	$-10,606,000	$1,927,000
Other Non Cash Items	$-200,000	$788,000	$-1,515,000	$-1,612,000
Asset Impairment Charge	$0	$0	$916,000	$3,646,000
Amortization Of Securities	$-10,179,000	$-12,731,000	$-12,141,000	$-1,572,000
Deferred Tax	$-176,194,000	$0	$0	-
Deferred Income Tax	$-176,194,000	$0	$0	-
Depreciation Amortization Depletion	$19,449,000	$19,445,000	$11,647,000	$2,706,000
Depreciation And Amortization	$19,449,000	$19,445,000	$11,647,000	$2,706,000
Net Foreign Currency Exchange Gain Loss	$9,685,000	$-5,910,000	$5,949,000	$0
Net Income From Continuing Operations	$287,202,000	$5,752,000	$-78,020,000	$-108,180,000
Net Intangibles Purchase And Sale	-	-	$0	$0
Purchase Of Intangibles	-	-	$0	$0
Interest Paid Supplemental Data	-	-	-	$1,979,000
Amortization Cash Flow	-	-	-	-
Amortization Of Intangibles	-	-	-	-
Depreciation	-	-	-	-

Fetched: 2026-06-17